Ukuthenga kuphi i-Velcatasvir (i-Epclusa)? Velpatasvir (Velpanat, Velasof): intengo eRussia

I-Velpatasvir yisidakamizwa esisha esakhiwe yiGileyadi Inc. Isetshenziswa ekwelapheni kwesifo sofuba esiphezulu C. Leli phepha laliphumelela ngokukhethekile kuma-genotypes amabili no-3 we-hepatitis. Futhi ngenkathi enomuthi kuye emandleni omthelela akukho okulinganayo.

Ukuhlanganiswa kwe-sophosbuvira (400 mg) ne-velpathasvir (100 mg) yenzelwe ukulwa nanoma iyiphi i-genotype yesifo se-hepatitis C futhi inikeza umphumela we-100%, noma ngabe ukwelashwa kwangaphambilini kwehlulekile. Yenziwa e-US, i-giant giant eGileyadi Inc, futhi itholakala ngendlela yamathebulethi abizwa ngokuthi "i-Epclus."

I-Sophosbuvir kule ndlela yokulungisa i-RNA polymerases, lapho igciwane likopisha khona i-RNA, kanye nezenzo ze-velpathasvir kwi-NS5B polymerase, ephazamisa ukwethulwa kwegciwane lomzimba wegciwane emangqamuzaneni anempilo.

Ngingayithola kuphi i-vellpataswir ne-sophosbuvir ekulungiselelweni okuhlangene?

Kunzima ukuthenga amaphilisi e-Epclus, ngoba abiza ama-euro angu-60,000 enkampanini yokwelapha inyanga ezintathu, okuyinto, njengoba uqonda, iyabiza kakhulu ngenxa yeziguli eziningi kakhulu. Ngenhlanhla, ngo-2017, iGileyadi yanikezela izinkampani zaseNdiya iNATCO PHARMA neHETERO ngelayisensi engavumelekile yokukhiqiza izakhi ezilayisensi: VELPANAT (NATCO) neVELASOF (HETERO). Thenga i-velpatasvir + sophosbuvir manje ongayenza eNdiya ngentengo efanele kakhulu.

Inhlanganisela yeziguli eziningi - i-sophosbuvir + velpathaswir - ingathengwa kusayithi lenethiwekhi enkulu yokusabalalisa yase-Indian WWW.HCV24.COM .

Ukuze uhlele i-Epclusa ejwayelekile kuwebhusayithi yenkampani yaseNdiya, udinga ukuba nemibhalo eqinisekisa ukuthi udinga ngempela ukwelapha isifo sofuba.

Ukuze kuqinisekiswe ukuthi iziguli azizange zibe nokungabaza, sisho ukuthi i-generic iyi-analog ephelele yomuthi ogqamile owenziwe ngokusho kobuchwephesha obukhona kakade, ngakho-ke ayihlanganisi izindleko zezindleko zokucwaninga nokunyusa emakethe. Kungenxa yalokhu, futhi hhayi izinga elibi kunabo bonke, njengoba abanye becabanga, ukuthi ama-generics anakho okungabizi kakhulu kunemikhiqizo emikhiqizo.

Ukungafani

Njengoba ubona, i-remedy echazwe iyadingeka ekulwa nesifo esibucayi. Kodwa ngaphambi kokuba uthenge "i-Velpathaswir" noma inhlanganisela yayo ne-sophosbuvir, kufanele wazi ukuthi akukhuthazwa ukusebenzisa lesi sidakamizwa kwabesifazane ngesikhathi sokukhulelwa nokuncelisa, futhi nakwamadoda, uma ukhulelwe umlingani.

Ungabeki leli thuluzi iziguli ezingaphansi kweminyaka engu-18, futhi ungazibekezelelani ngabanye izingxenye ezisebenzayo zomuthi.

Isetshenziswa ngokuqapha ekwelapheni iziguli ezineminyaka engaphezu kwengu-65, kanye nalabo ababhekene nokuhluleka okukhulu kwezinsola.

Indlela yokusebenza

Isidakamizwa "i-Epclus", kanye nesimo sayo esijwayelekile (i-sophosbuvir + velpatasvir), intengo nezindlela zokusebenzisa ezixoxwa ngazo esihlokweni sethu, kuthathwa kanye ngosuku ngosuku lwethebhulethi eyodwa. Inkambo yokwelashwa iqhubeka, njengoba umthetho, izinyanga ezintathu.

Ngaphambi kokuba iziguli ze-cirrhosis ezithengisiwe (izigaba B no-C) zinconywa ukuba zandise inkambo emavikini angu-24. Futhi ukwelashwa kuleli cala kwenziwa ngokuhambisana nomuthi "Ribavirin".

Imiphumela emibi

Ngaphambi kokuthenga "i-Velpathaswir" noma inhlanganisela yayo, umuntu kufanele futhi aqaphele imiphumela emibi engase ivele ngesikhathi sesicelo. Ngakho, iziguli ziyakwazi ukugcina:

• Isizungu;
• Ukuphulwa kokunakwa kanye nenkumbulo;
• Ukuphelelwa amandla;
• Ukuphefumula;
• Isifo sohudo;
• I-anemia;
• I-edema yedatha;
• I-Hypothyroidism;
• Rash;
• Ukuphendula kwe-allergen;
• Izithombeensitivity.

Amacala okudlula izidakamizwa ezidakamizwa "Velpatasvir", ongayithengisa endaweni ehlongozwayo, ayengabonwa.